comparemela.com

Latest Breaking News On - Hedge funds weigh in on lexicon pharmaceuticals - Page 1 : comparemela.com

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Sees Large Growth in Short Interest

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 23,440,000 shares, a growth of 16.5% from the April 15th total of 20,120,000 shares. Based on an average daily volume of 4,450,000 shares, […]

China
Leerink-partnrs
Cantor-fitzgerald
Lexicon-pharmaceuticals
Principal-securities-inc
Commonwealth-equity-services
Needham-company
Hedge-funds-weigh-in-on-lexicon-pharmaceuticals
National-association
Lexicon-pharmaceuticals-inc
China-universal-asset-management-co
Lexicon-pharmaceuticals-company-profile

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Reaffirmed by Needham & Company LLC

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Reaffirmed by Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Swiss
Leerink-partnrs
Lexicon-pharmaceuticals
Lexicon-pharmaceuticals-inc
Swiss-national-bank
Needham-company
Hedge-funds-weigh-in-on-lexicon-pharmaceuticals
Sg-americas-securities
Commonwealth-equity-services
National-association
News-ratings-for-lexicon-pharmaceuticals-daily

Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Up 5.9%

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) shares rose 5.9% during trading on Thursday . The stock traded as high as $2.19 and last traded at $2.16. Approximately 284,943 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 4,708,926 shares. The stock had previously closed at $2.04. […]

Switzerland
Swiss
Lexicon-pharmaceuticals-inc
Lexicon-pharmaceuticals-company-profile
Hedge-funds-weigh-in-on-lexicon-pharmaceuticals
Nasdaq
Commonwealth-equity-services
Lexicon-pharmaceuticals
Lexicon-pharmaceuticals-price-performance
News-ratings-for-lexicon-pharmaceuticals-daily
Sg-americas-securities

Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Down 6.8%

Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) were down 6.8% during trading on Tuesday . The company traded as low as $2.51 and last traded at $2.62. Approximately 3,249,144 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 4,932,042 shares. The stock had previously closed […]

Lexicon-pharmaceuticals-price-performance
News-ratings-for-lexicon-pharmaceuticals-daily
Hedge-funds-weigh-in-on-lexicon-pharmaceuticals
Lexicon-pharmaceuticals
Victory-capital-management-inc
Stifel-financial-corp
Nasdaq
Lexicon-pharmaceuticals-inc
Get-free-report
Financial-corp
Street-group

Traders Buy Large Volume of Lexicon Pharmaceuticals Call Options (NASDAQ:LXRX)

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders purchased 10,911 call options on the company. This is an increase of 1,740% compared to the average volume of 593 call options. Lexicon Pharmaceuticals Trading Up 3.4 % Shares of Lexicon Pharmaceuticals stock traded […]

Montreal
Quebec
Canada
Baystate-wealth-management
Lexicon-pharmaceuticals
Hedge-funds-weigh-in-on-lexicon-pharmaceuticals
Lexicon-pharmaceuticals-trading
News-ratings-for-lexicon-pharmaceuticals-daily
Lexicon-pharmaceuticals-inc
Kestra-advisory-services
Raymond-james-associates

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.